Current Clinical Studies - Keystone Clinical Studies

Your Treatment
Options Start Here

Alzheimer's Disease Depression Parkinson's Disease
ALZHEIMER'S STUDIES

Preclinical/Asymptomatic Alzheimer's Disease

Currently Enrolling


This study is for individuals who do not yet have symptoms of memory or functional loss associated with Alzheimer's Disease. Individuals with a family history or general concern about developing Alzheimer's Disease are welcome to screen for this study. If eligible, this study requires bimonthly or monthly office visits for infusion treatments over a period of 4 years.

Basic Criteria:

  • Between 55-80 years of age
  • Not experiencing any subjective memory issues
  • Requires a study partner to attend some visits

See the study website for more information: https://www.aheadstudy.org

Mild Cognitive Impairment/Early Alzheimer's Disease

Currently Enrolling


This study requires monthly office visits for infusion treatments for a period of 2.5 years (minimum) up to 4.5 years (maximum), with a 13 week follow up period.

Basic Criteria:

  • Between 55-80 years of age
  • Gradual and progressive change in memory for more than 6 months
  • Requires a study partner to attend some visits

Mild Cognitive Impairment/Early Alzheimer's Disease

Currently Enrolling


This study requires monthly office visits for a period of 1.5 years (minimum) up to 2.5 years (maximum) with a 4 week follow up period. Eligible patients dose once daily with an oral medication.

Basic Criteria:

  • Between 60-85 years of age
  • Gradual and progressive change in memory for more than 6 months
  • Requires a study partner to attend all visits

Mild Cognitive Impairment/Early Alzheimer's Disease

Upcoming Enrollment - February 2022


This study requires monthly office visits for a period of 1.5 years (minimum) up to 2.5 years (maximum) with a 4 week follow up period. Eligible patients dose once daily with an oral medication.

Basic Criteria:

  • Between 60-85 years of age
  • Gradual and progressive change in memory for more than 6 months
  • Requires a study partner to attend all visits

Mild to Moderate Alzheimer's Disease

Currently Enrolling


This study requires office visits every 3 months over a period of approximately 1.5 years. Eligible patients dose twice daily with an oral medication.

Basic Criteria:

  • Between 50-87 years of age
  • Gradual and progressive change in memory for more than 6 months
  • Requires a study partner to attend all visits

Mild to Moderate Alzheimer's Disease

Currently Enrolling


This study requires bimonthly office visits (for the first few visits) and then monthly office visits over a period of 6 months, with a 4 week follow up period. Eligible patients dose with daily injections and will be given the opportunity to participate in a 1 year, long term extension study after completing this initial study.

Basic Criteria:

  • Between 55-85 years of age
  • Gradual and progressive change in memory for at least 12 months
  • Noticeable difficulty with memory and functioning
  • Requires a reliable study partner to attend all visits and assist with medication administration
DEPRESSION STUDIES

Depression

Currently Enrolling


This study requires office visits lasting 1-2 hours over a 1 year period, visits vary in frequency. Eligible patients dose with an oral medication.

Basic Criteria:

  • Between 18-75 years of age
  • If currently taking an antidepressant, must be on the same dose for at least 60 days
  • If not currently taking an antidepressant, must be off any antidepressants for at least 60 days
  • Not currently working night shift

Depression

Currently Enrolling


This study requires weekly visits for 4 weeks, with a 14 day follow up period. Eligible patients dose once daily with an oral medication and will be given the opportunity to participate in a 1 year, long term extension study after completing this initial study.

Basic Criteria:

  • Between 18-65 years of age
  • Body Mass Index (BMI) between 18-30 kg/m2 (check your BMI here here)
  • Feeling depressed for a minimum of 8 weeks
  • Currently taking an antidepressant for a minimum of 6 weeks with little to no improvement in symptoms

Depression

Currently Enrolling


This study requires monthly office visits over 1 year, with a 4 week follow up period. Eligible patients dose once daily with an oral medication.

Basic Criteria:

  • Between 18-65 years of age
  • Feeling depressed for a minimum of 8 weeks
  • Currently taking an antidepressant for a minimum of 6 weeks with little to no improvement in symptoms

Depression

Currently Enrolling


This study requires weekly office visits over a period of approximately 7 weeks. Eligible patients dose once daily with oral medication.

Basic Criteria:

  • Between 18-65 years of age
  • Feeling depressed for a minimum of 8 weeks
  • Currently taking one antidepressant for a minimum of 6 weeks with little to no improvement in symptoms
PARKINSON'S STUDIES

Parkinson's Disease Dementia

Upcoming Enrollment planned February 2022


This study requires 9 office visits over a period of approximately 7 months. Eligible patients dose with daily injections.

Basic Criteria:

  • Between 40-85 years of age
  • Diagnosed with Parkinson's Disease Dementia
  • Requires a study partner to attend all visits and assist with medication administration

PARTICIPATE IN A CLINICAL STUDY

Clinical trials are imperative for the process of improving treatment outcomes for millions of patients suffering from chronic or life-threatening conditions. Clinical trials are required by the FDA to demonstrate the safety and efficacy of new treatments before they are approved.

See if you qualify to participate in a clinical study



Learn More About Clinical Trials.